Nutan DeJoubner, M.D.
Dr. Nutan DeJoubner is a board-certified internal medicine/medical oncology physician in Pensacola, Florida. She specializes in providing the highest quality health care to adult cancer patients. Dr. DeJoubner is a fellowship-trained and works as a part of the Baptist Cancer Institute. She welcomes new patient appointments in Pensacola and Gulf Breeze.
Kasturba Medical College (KMC) Manipal
Internal Medicine, Atlanta Medical Center
Internal Medicine, Atlanta Medical Center
Hematology-Oncology, Emory University School of Medicine
Winship Cancer Institute, Atlanta, GA
American Medical Association
American Society of Hematology
American Society of Clinical Oncology
Conducted a clinical trial to identify the clinical significance and potential role for use of circulating endothelial, progenitor and immune cells as prognostic markers in patients with locally advanced and metastatic lung cancer.
Novel agents for diffuse large B-cell lymphoma. Sinha, Rajni; DeJoubner, Nutan; Flowers, Christopher. Expert opinion on investigational drugs. Volume 20, Number 5, May 2011, pp. 669-680(12).
Prognostic impact of circulating endothelial cell counts in patients with advanced non-small cell lung cancer. Nutan Jyothi DeJoubner, Hyunseok Kang, Qunna Li, Wayne A C Harris, Rena Stewart, Alicia Price, Arshed Quyyumi, Scott A. Kono, Suresh S. Ramalingam, Taofeek Kunle Owonikoko, Fadlo Raja Khuri, Edmund K. Waller. JCO 30,2012(Suppl;abstr e20145)
Examining the Outcome of Watchful Waiting(WW) Among US Patients with Advanced Stage Follicular Lymphoma(FL). Rajni Sinha, MD, MRCP1, Michelle Byrtek, PhD, Nutan J. DeJoubner, MD, Ajay K. Nooka, MD, MPH, FACP, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Ryan M Ziemiecki, MS, Jamie H. Hirata, PharmD, Brian K Link, MD and Christopher R Flowers, MD. ASH 2011( Abstr 775)
Examination of the follicular lymphoma international prognostic index (FLIPI) in the national LymphoCare study (NLCS): A US patient cohort treated predominantly in community practices. A. K. Nooka, N. J. DeJoubner, C. Nabhan, X. Zhou, M. Taylor, M. Byrtek, T. P. Miller, J. W. Friedberg, A. D. Zelenetz, B. K. Link, J. R. Cerhan, H. Dillon, D. Levy, J. Hirata, C. Flowers. Abstract 8026, American Society of Oncology, Chicago June 2011
Prognostic significance of dendritic cells in allogenic progenitor hematopoietic transplant. J Clin Oncol 26: 2008 (May 20 suppl; abstr 7044) N. DeJoubner, Z. Ali, M. Grasier, E. Hamilton, C. Flowers, S. Lonial, A. Langston, E. K. Waller.
Dr. DeJoubner is also fluent in Hindi, Konkani and Kannada. She enjoy's time with her children as well as cooking, adventure sports, traveling, reading, dancing and swimming.
To learn more about Dr. DeJoubner and her medical oncology - hematology practice, please visit the practice page.
Dr. DeJoubner is an employed physician with Baptist Medical Group and serves as a physician within the Baptist Cancer Institute of Baptist Health Care. To learn more about the Baptist Cancer Institute, click here.
Meet Your Doctor
What led you to become a doctor or choose your focus of medicine?
I was inspired to become a doctor when I experienced that a doctor could make a huge impact in people’s lives while I was doing community service at a local hospital. My curious, compassionate and dedicated nature would be put to best use in the field of medicine, which is why I chose to be a doctor.
What about your line of work do you find most rewarding and why?
The fact that I can make a difference to patients lives for the better. It is very satisfying to help patients feel good, enhancing their quality of health and ultimately their life.
What is something about you that only your patients would know?
I listen to my patients and together we make decisions about their health. My patients know I care for them.
How would a patient describe you?
Compassionate, knowledgeable, understanding and thorough.
What’s your proudest moment as a doctor?
When I got a voicemail from my patients son, who called to advise me of her death and mentioned, how I had made a difference in her life and how much she appreciated my care for her, he mentioned that I made her feel like a person and not just another cancer patient. She had given me a beautiful card and a pair of earrings the Christmas before she died, which I still hold very dear.
In your opinion, what’s the most important factor in a doctor-patient relationship?
In my opinion, I believe that mutual trust and respect are the most important factors in a doctor-patient relationship.
What can a patient expect when they have you as a doctor?
I will be always there for them and work very hard for them. I will work in their best interest and do what is right, working diligently to make sure that they receive the best and the latest medical treatment available to treat and fight their disease.
What do you find most encouraging about the work you do?
Seeing the patient smile and regain their confidence and life back makes my life as a oncologist very satisfying.
What are your top priorities with every patient you see?
To educate the patient about their disease, give them all the available options and together work on the most effective plan towards cure. Hence enhancing the quality of their health and ultimately their life.
Is there anything more or extra you would like prospective patients to know about you?
I am inspired by my patients and very thankful for the opportunity to serve them. I am dedicated to giving the best care one could possibly get. I would treat my patients like my family. I am very approachable and would be available if and when they needed me.